Tuberculosis research in India and China: From bibliometrics to research policy

Current Science

Volumn 82, Issue 8, 2002, Pages 933-947

  Arunachalam, Subbiah ^a   Gunasekaran, Subbiah ^a  

^a M S SWAMINATHAN RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041367672     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. The Global Alliance for TB Drug Development, Press release datelined Brussels, 23 March 2001.
2. Glaser, N., GATE, 2000, 18, 8-10.
3. Frieden, T. R., Lerner, B. H. and Rutherford, B. R., Lancet, 2000, 355, 1088-1092.
4. Dye, C., Scheele, S., Dolin, P., Pathania, V. and Raviglione, M. C., J. Am. Med. Assoc., 1999, 282, 677-686.
5. Global Tuberculosis Control, WHO Report 2000, World Health Organization, Geneva, Switzerland, WHO/CDS/TB/2000.275, p. 4; 10.
6. Balasangameshwara, V. H., Status of Tuberculosis in India - 2000 (eds Nayak, R., Shaila, M. S. and Ramananda Rao, G.), Society for Innovation and Development, Indian Institute of Science, Bangalore, 2000, pp. 41-46.
7. 'Virtual' research group to focus on TB cure, item 56, SPIN, The Wellcome Trust, 2 April 2001, 497 (quoting Financial Times, 27 March 2001, p. 10).
8. 'Virtual' research group to focus on TB cure, item 56, SPIN, The Wellcome Trust, 2 April 2001, 497 (quoting Financial Times, 27 March 2001, p. 10).
9. The Global Alliance for TB Drug Development, Press release datelined Bangkok, 10 October 2000.
10. Global Forum for Health Research, The 10/90 Report on Health Research 2000.
11. Coe, G. A. and Banta, D., Int. J. Technol. Assess. Health Care, 1992, 8, 255-267.
12. De, S. N., Nature, 1959, 183, 1533-1534.
13. De, S. N. and Chatterjee, D. N., J. Pathol. Bacteriol., 1953, 66, 559-562.
14. De, S. N., Bhattacharya, K. and Sarkar, J. K., ibid, 1956, 71, 201-209.
15. Garfield, E., in Essays of an Information Scientist, Towards Scientography, 1986, vol. 9, pp. 103-111.
16. Curr. Sci., 1990, 59, 623-627.
17. Arunachalam, S., Curr. Sci., 1997, 72, 912-922.
18. Arunachalam, S., Natl. Med. J. India, 1998, 11, 27-34.
19. Geiter, L., Ending Neglect: The Elimination of Tuberculosis in the United States, Institute of Medicine, Washington DC, National Academy Press, 2000.
20. Brown, S., Statement made at a press conference held at Washington DC, 21 March 2001.
21. Orfinger, B., 23 March 2001, http://www.disasterrelief.org/ Disasters/010322TBday/ accessed on 27 July 2001.
22. World Health Report 1999, World Health Organization, WHO, Geneva, Switzerland, 1999, p. 1.
23. Michaud, C. M., Murray, C. J. L. and Bloom, B. R., J. Am. Med. Assoc., 2001, 285, 535-539.
24. Paul Nunn, Annual forum 3, Geneva, June 1999, http://www. globalforumhealth.org/docs/forum3doc391.htm accessed on 26 June 2001.
25. WHO, http://www.who.int/tdr/diseases/tb/whyresearch.htm accessed on 27 March 2001.
26. Tuberculosis Prevention Trial, Madras, Indian J. Med. Res. (Suppl), 1980, 72, 1-74.
27. Tuberculosis Research Centre, ibid, 1999, 110, 56-69.
28. Ogden, J. and Porter, J., Dev. Res. Insights, December 1999, 32.
29. Giorgio Roscigno, Global alliance for TB Drug Development Address to the Asian R&D Coalition Conference, Penang, 2 May 2001; http://www.tballiance.org/pdf.speech/gr_ardc.pdf.
30. AstraZeneca press release 25 April 2001; http://www.astrazeneca. com/NewsSection/NewsReleases/press_release_138.html.
31. Arunachalam, S. and Gunasekaran, S., Curr. Sci., 2001, 82 (accepted for publication).
32. Arunachalam, S. and Gunasekaran, S., International Society for Health Research - Indian Section, Annual Conference 2002, Sri Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvanathapuram, 1-3 February 2002.
33. Global Tuberculosis Control, WHO Report 2001, World Health Organization, Geneva, Switzerland, WHO/CDS/TB/2001.287.
34. Arunachalam, S., in The Web of Knowledge - A Festschrift in Honor of Eugene Garfield (eds Cronin, B. and Atkins, H. B.), Information Today Inc. and The American Society for Information Science, Medford, NJ, USA, September 2000, pp. 215-231.
35. Arunachalam, S., Scientometrics, 2001, 52, 235-259.
36. Acosta-Cazares, B., Browne, E., LaPorte, R. E., Neuvians, D., de Camargo, K. R., Tapia-Conyer, R. and Yang Ze., Scientific colonialism and safari research, Clinmed/2000010008.
37. Butler, D., Nature, 2000, 403, 692.
38. WHO press release dated 9 July 2001; http://www.who.int/inf-pr-2001/en/pr2001-32.html
39. Rowson, M., Br. Med. J., 2001, 323, 186.
40. Oxfam Report, See Financial Times, London, 19 July 2001, p. 12, and SPIN, The Wellcome Trust, 23 July 2001, 513, p. 7, item 45.
41. Oxfam Report, See Financial Times, London, 19 July 2001, p. 12, and SPIN, The Wellcome Trust, 23 July 2001, 513, p. 7, item 45.
42. Hopes for Public Private Genome Research, SPIN, The Wellcome Trust, 30 July 2001, 514, p. 6, item 40.
43. O'Brian, R. J. and Nunn, P. P., Am. J. Respir. Crit. Care Med., 2001, 163, 1055-1058.
44. NIAID Global Health Research Plan for HIV/AIDS, Malaria, and Tuberculosis, National Institute of Allergy and Infectious Diseases, 7 May 2001.
45. Sen, K. and Bonita, R., Lancet, 2000, 356, 577-582.
46. Collins, C. and Coates, T. J., Am. J. Public Health, 2000, 90, 1389-1390.
47. Hicks, E. K., Cabo, P. G. and Rikken, F., Knowledge Policy, 1993-1994, 6, 79-98.
48. The Global Impact of Drug Resistant Tuberculosis, Open Society Institute, Harvard Medical School, 1999.